A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naïve Acute Myeloid Leukemia (AML): DLIT-AML

Clinical trial NCT07014462 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07014462
Sponsor: University of Vermont
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

AML - Acute Myeloid Leukemia

Start date: 2025-09-01
Primary completion: 2029-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.